Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Swanson

Showing results (81-90 of 176) with videos related to

Pageof 18
Sort By:
Orthopedics|February 14, 2008
Osteoporotic vertebral fractures and collapse with intravertebral vacuum sign (Kümmel's disease)Ioannis P Pappou, Elias C Papadopoulos, Andrew N Swanson, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1991
Activity of temafloxacin against respiratory pathogensR N Swanson, D J Hardy, D T Chu, et al.
The Journal of Laboratory and Clinical Medicine|July 1, 1983
Dimethyl sulfoxide inhibits bioactivation of sulindacB N Swanson, V K Boppana, P H Vlasses, et al.
Kidney International|December 1, 1994
AT4 receptors: specificity and distributionJ W Harding, J W Wright, G N Swanson, et al.
Journal of Clinical Pharmacology|July 1, 1982
A comparative pilot study of enalapril, a new converting enzyme inhibitor, and hydrochlorothiazide in essential hypertensionR K Ferguson, P H Vlasses, J D Irvin, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1983
Norfloxacin disposition after sequentially increasing oral dosesB N Swanson, V K Boppana, P H Vlasses, et al.
The Journal of Investigative Dermatology|September 18, 1998
Perturbed epidermal pterin metabolism in Hermansky-Pudlak syndromeK U Schallreuter, W D Beazley, N A Hibberts, et al.
Research Communications in Chemical Pathology and Pharmacology|September 1, 1981
Angiotensin converting enzyme activity in human serum: relationship to enzyme inhibitor in vivo and in vitroB N Swanson, M Hichens, P Mojaverian, et al.
The Laryngoscope|April 1, 1976
Pre and post-glycerol special audiometric tests battery results in endolymphatic hydropsS N Swanson, I K Arenberg, W F Carver, et al.
Journal of Child and Adolescent Psychopharmacology|October 31, 2006
A double-blind placebo-controlled pilot study of olanzapine in childhood/adolescent pervasive developmental disorderEric Hollander, Stacey Wasserman, Erika N Swanson, et al.
Pageof 18

Showing results (81-90 of 176) with videos related to

Sort By:
Pageof 18
Orthopedics|February 14, 2008
Osteoporotic vertebral fractures and collapse with intravertebral vacuum sign (Kümmel's disease)Ioannis P Pappou, Elias C Papadopoulos, Andrew N Swanson, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1991
Activity of temafloxacin against respiratory pathogensR N Swanson, D J Hardy, D T Chu, et al.
The Journal of Laboratory and Clinical Medicine|July 1, 1983
Dimethyl sulfoxide inhibits bioactivation of sulindacB N Swanson, V K Boppana, P H Vlasses, et al.
Kidney International|December 1, 1994
AT4 receptors: specificity and distributionJ W Harding, J W Wright, G N Swanson, et al.
Journal of Clinical Pharmacology|July 1, 1982
A comparative pilot study of enalapril, a new converting enzyme inhibitor, and hydrochlorothiazide in essential hypertensionR K Ferguson, P H Vlasses, J D Irvin, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1983
Norfloxacin disposition after sequentially increasing oral dosesB N Swanson, V K Boppana, P H Vlasses, et al.
The Journal of Investigative Dermatology|September 18, 1998
Perturbed epidermal pterin metabolism in Hermansky-Pudlak syndromeK U Schallreuter, W D Beazley, N A Hibberts, et al.
Research Communications in Chemical Pathology and Pharmacology|September 1, 1981
Angiotensin converting enzyme activity in human serum: relationship to enzyme inhibitor in vivo and in vitroB N Swanson, M Hichens, P Mojaverian, et al.
The Laryngoscope|April 1, 1976
Pre and post-glycerol special audiometric tests battery results in endolymphatic hydropsS N Swanson, I K Arenberg, W F Carver, et al.
Journal of Child and Adolescent Psychopharmacology|October 31, 2006
A double-blind placebo-controlled pilot study of olanzapine in childhood/adolescent pervasive developmental disorderEric Hollander, Stacey Wasserman, Erika N Swanson, et al.
Pageof 18